Shell PLC vs Smith & Nephew plc — how do they compare? Shell PLC trades at $87.12 (market cap $235.24B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Shell PLC is far larger — about 18.6× Smith & Nephew plc's market cap, and Shell PLC pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| SHEL | SNN | |
|---|---|---|
Market Cap | $235.24B | $12.64B |
Sector | Energy | Health |
52-Week High | $94.15 | $38.70 |
52-Week Low | $70.31 | $28.73 |
Enterprise Value | $287.77B | $15.41B |
Dividend Yield | 3.63% | 2.57% |
Trailing returns across standard periods
Latest headlines on both assets
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →